[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Srivastava et al., 1988 - Google Patents

Recent developments in blood cell labeling research

Srivastava et al., 1988

View PDF
Document ID
12717708907652138813
Author
Srivastava S
Straub R
Meinken G
Publication year

External Links

Snippet

A number of recent developments in research on blood cell labeling techniques are presented. The discussion relates to three specific areas:(1) a new in vitro method for red blood cell labeling with/sup 99m/Tc;(2) a method for labeling leukocytes and platelets …
Continue reading at www.osti.gov (PDF) (other versions)

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K51/00Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus organic compounds
    • A61K51/08Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/10Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody or an immunoglobulin, or a fragment thereof, e.g. a camelised human single domain antibody, or the Fc fragment of an antibody
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K51/00Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus organic compounds
    • A61K51/0474Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K51/00Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/12Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
    • A61K51/1203Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules in a form not provided for by groups A61K51/1206 - A61K51/1296, e.g. cells, cell fragments, viruses, virus capsides, ghosts, red blood cells, viral vectors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K2123/00Preparations for testing in vivo
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K49/00Preparations for testing in vivo
    • A61K49/06Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/80Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood groups or blood types or red blood cells
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay
    • G01N33/531Production of immunochemical test materials

Similar Documents

Publication Publication Date Title
EP0111415B1 (en) Process for making lyophilized radiographic imaging kit
Eckelman et al. Radiopharmaceuticals labelled with technetium
DE3850497T2 (en) METHOD FOR MARKING ANTIBODIES WITH A METALLION.
CA1245980A (en) Physiologic chemical method of labeling protein substances with the radionuclides of indium
US4416865A (en) Radiopharmaceuticals for localization of thromboembolic disease
US4647445A (en) Radiolabelled lipoproteins and method for making same
US4707353A (en) Radiographic imaging agents
US5130118A (en) Methods and materials for the preparation of metal labelled antibody solutions
US4272503A (en) Reductant composition for technetium-99m and method for making technetium-99m labelled ligands
US4010251A (en) Scanning agent composition and use in imaging liver and for biliary function
EP0083129A1 (en) Method of preparing radionuclide-labelled proteins, in particular antibodies or antibody fragments
US4443426A (en) Blood agent
US4293537A (en) Novel chemical method of labeling proteins with 99m Tc-Technetium at physiological condition
Bauer et al. In vivo/in vitro labeling of red blood cells with 99m Tc
CA1324317C (en) Stable radiodiagnostic products, and the preparation thereof
EP0169232B1 (en) Composition for technetium-99m labelling of proteinaceous material
Srivastava et al. Recent developments in blood cell labeling research
JPH0445107B2 (en)
Harwig et al. In vivo behavior of 99mTc-fibrinogen and its potential as a thrombus-imaging agent
Srivastava et al. Current state of the art of blood cell labeling
Hnatowich et al. The importance of pH and citrate concentration on the in vitro and in vivo behavior of radiogallium
EP0111414A2 (en) Radiographic imaging agents
Callahan Radiol&eled Red Blood Cells: Methods and Mechanisms
Srivastava et al. Radiolabeled antiplatelet monoclonal antibodies for the scintigraphic localization of in-vivo thrombi and vascular lesions
Srivastava Radiolabeled red blood cells: Status, problems, and prospects